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Abstract
Background: Intra-uterine contraception (IUC) involves the use of an intra-uterine device (IUD), a highly effective,
long-acting, reversible contraceptive method. Historically, the popularity of IUC has waxed and waned across
different world regions, due to policy choices and shifts in public opinion. However, despite its advantages and
cost-effectiveness for programmes, IUC’s contribution to contraceptive prevalence is currently negligible in
many countries.
This paper presents the results of a systematic review of the global literature on provider and lay perspectives
on IUC. It aims to shed light on the reasons for low use of IUC and reflect on potential opportunities for the
method’s promotion.
Methods: A systematic search of the literature was conducted in four peer-reviewed journals and four electronic
databases (MEDLINE, EMBASE, POPLINE, and Global Health). Screening resulted in the inclusion of 68 relevant
publications.
Results: Most included studies were conducted in areas where IUD use is moderate or low. Findings are similar
across these areas. Many providers have low or uneven levels of knowledge on IUC and limited training. Many
wrongly believe that IUC entails serious side effects such as pelvic inflammatory disease (PID), and are reluctant
to provide it to entire eligible categories, such as HIV-positive women. There is particular resistance to providing
IUC to teenagers and nulliparae. Provider opinions may be more favourable towards the hormonal IUD. Some
health-care providers choose IUC for themselves.
Many members of the public have low knowledge and unfounded misconceptions about IUC, such as the fear
of infertility. Some are concerned about the insertion and removal processes, and about its effect on menses.
However, users of IUC are generally satisfied and report a number of benefits. Peers and providers exert a strong
influence on women’s attitudes.
Conclusion: Both providers and lay people have inaccurate knowledge and misconceptions about IUC, which
contribute to explaining its low use. However, many reported concerns and fears could be alleviated through
correct information. Concerted efforts to train providers, combined with demand creation initiatives, could
therefore boost the method’s popularity. Further research is needed on provider and lay perspectives on IUDs
in low- and middle-income countries.
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Plain English summary
This article focuses on intra-uterine contraception
(IUC), which involves the use of an intra-uterine device
(IUD), a highly effective contraceptive method. The pro-
portion of contraceptive users choosing the IUD varies
across the world, but overall it is little used. In this art-
icle, we aimed to summarise what is known about the
opinions of health-care providers and members of the
public concerning IUC. Our aim was to better under-
stand why its use is low and whether there is any scope
to promote it further. We conducted a rigorous search
of scientific journals and electronic databases in order to
identify relevant articles, and found 68.
These studies suggest that many health-care providers
are reluctant to recommend the method because they
wrongly believe it has negative side effects. Although
teenagers and women with no children can use IUC
safely, many providers are unwilling to provide it to
them. Many members of the general public have low
knowledge or misunderstand how IUC works, for ex-
ample they fear that IUDs cause infertility. Others are
worried about how the device is inserted, or about how
it alters the menstrual cycle. However, women using
IUC are generally satisfied.
These findings are remarkably similar in studies from
across the world, and partly explain why the use of IUDs
is low. However, they also suggest that providing correct
information could reassure people about the method's
safety. Therefore, better training for health-care pro-
viders and awareness raising among the general public
could increase IUC’s popularity.
Background
Intra-uterine contraception (IUC) involves the use of an
intra-uterine device (IUD), a form of long-acting, re-
versible contraception (LARC). IUDs are among the
most effective contraceptive methods, with 8 pregnan-
cies per 1000 women in the first year of use for the
copper-bearing IUD, and 2 per 1000 women for the
levonorgestrel-releasing IUD or LNG-IUD (also known
as the intra-uterine system or IUS) [1]. The copper-
bearing IUD is effective for 10–12 years, and the LNG-
IUD for 5 years, both with immediate fertility return
once removed [2]. Because they need to be inserted and
removed by a health-care provider, the likelihood of
user error is limited. These features make IUDs highly
cost-effective for programmes [3, 4]. IUDs are suitable
for groups who may have difficulty accessing contra-
ception, such as adolescents [5] and HIV-positive
women [6, 7]. The copper-bearing IUD is also useful
for women wishing to avoid side-effects associated with
hormonal contraception, whereas the LNG-IUD, pro-
ducing lighter periods, is protective against anaemia
[2]. Furthermore, IUC can be used postpartum [8] and
postabortion [9], and is also the most effective form of
emergency contraception [10].
Today, although IUC is used by large numbers of
women, its global distribution is uneven [11]. In a few
countries, including China and most of Central Asia,
IUDs constitute at least half of all contraceptive use. In
Northern Africa and the Middle East, they represent
about a quarter of all use, and in parts of Europe, about
a fifth. In the past two decades, levels have remained
broadly constant or declined slightly in these areas. Con-
versely, in the Americas, IUC’s share of use is generally
well below 10%, despite a spike in the USA in recent
years. Finally, in sub-Saharan Africa, South Asia and the
Pacific region, the contribution of IUDs to the method
mix is minimal [11]. In sub-Saharan Africa, although in-
creasing numbers of women wish to limit future births
[12], the majority are using short-acting methods [13],
and the current rise in contraceptive prevalence is
largely driven by injectables [14].
Two interacting factors are most helpful in explaining
this degree of geographical variation. Firstly, early pro-
grammatic choices by certain governments dramatically
shaped the contraceptive mix available to whole genera-
tions. For example, in the Soviet Union, the IUD was
promoted because it was locally produced and affordable
[15], while elsewhere the lack of foreign aid, or the
preferences of donors, influenced the method mix [16].
Secondly, contraceptive methods fall in and out of
favour among health providers and clients. Reverbera-
tions of the 1970s Dalkon Shield scandal were felt in the
US for several decades, and led to the virtual disappear-
ance of IUDs [17]. The dominance of certain methods
limits local providers’ knowledge and familiarity with
others, leading to a reluctance to recommend them. In
the case of IUDs, this is particularly relevant because
health-care providers need to undergo special training
and to practice insertion regularly in order to maintain
skills and confidence. In turn, the opinion of providers,
coupled with the exposure to experienced peers, has a
strong impact on potential users’ views [18].
It has long been acknowledged that the availability of a
range of contraceptive methods is most likely to meet
the needs of individuals [19]. People may be reluctant to
start using a method unless they know of and can access
one that meets their requirements. In addition, if only a
small number of methods are available, those experien-
cing side-effects may abandon contraception altogether
[20]. Increasing the number of contraceptive options,
therefore, tends to drive up overall use [21]. IUDs, with
their specific features, are a valuable component of the
method mix. Exploring provider and lay/user preferences
regarding IUC can shed light on current patterns of use,
and illustrate the potential which exists for its promo-
tion in countries where it is little used.
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Existing reviews on IUC have covered barriers to up-
take more generally, with an emphasis on access [22], or
have focused on provision to adolescents [23]. This art-
icle is based on a systematic search of the literature
which was conducted as part of a broader research pro-
ject on IUC [24]. Drawing on a relevant subset of re-
sults, it aims to comprehensively summarise and
interpret recent global findings on health provider and
lay perspectives on use of IUC.
Methods
A search was conducted in mid-December 2015 with
the aim to retrieve articles from peer-reviewed journals
and grey literature, published from 2010 to 2015 in any
country, concerning provider and lay perspectives on
IUC, facilitators and barriers, or describing interventions
aimed at increasing the uptake and continued use of the
method. “Provider perspectives” are those of all cadres
of person providing health-care services, including in fa-
cilities and in the community. “Lay perspectives” are
those of all people who are not health-care providers, in-
cluding but not limited to users and potential users of
contraception. We searched Medline, Popline, Embase
and Global Health electronic databases using keywords
and subject headings. This search was preceded by a
manual search of four journals (Contraception, the
European Journal of Family Planning and Reproductive
Health Care, Perspectives on Sexual and Reproductive
Health, and International Perspectives on Sexual and Re-
productive Health) in order to establish key words that
would capture the relevant literature. For the database
searches, no limitation was set on language, but search
terms were in English. Where possible, a limitation was
set on keywords being present in the Title or Abstract,
and to human subjects. For the detailed search strategy,
see Additional file 1.
Following the elimination of duplicates, the titles and
abstracts of 4199 records were individually screened by
MD and LB. Studies of safety, efficacy, contraindications
and clinical management, and of IUC as emergency
contraception were excluded. Studies were retained
based on their thematic relevance only, and the quality
of the evidence was not systematically graded. The
searches resulted in a total of 532 relevant references
(Fig. 1). Excluded articles did not contain specific infor-
mation related to use of IUC or IUC as part of LARC,
or were clinical or biomedical in nature. From the 376
publications for which full texts were reviewed, 68 ori-
ginal studies were included in this review. These were all
cross-sectional, descriptive surveys, or qualitative studies.
Nine studies reported perspectives of both providers and
lay people, 25 studies reported provider perspectives only
and 34 studies reported lay people’s perspectives only.
Details of the studies are in Additional file 2.
Results
Provider perspectives
A total of 34 studies on provider perspectives were iden-
tified (including 9 which also reported on lay perspec-
tives). These included 11 publications from the USA and
13 from Asia, Latin America and Africa. A further 7
studies related to European and other high-income
countries. Three papers were based on multi-country
data.
Knowledge, training and attitudes
Our findings show that many providers across the world
have low or uneven levels of knowledge, limited training,
and negative attitudes towards IUC, although some
choose the method for themselves.
Qualitative studies report that in Cambodia, village
health workers share very much the same misconcep-
tions about IUDs as the villagers themselves [25],
whereas in Pakistan, insufficient training is the main rea-
son for providers’ reluctance to provide IUDs, alongside
perceived lack of demand [26]. Complaints about lack of
training were also a common theme in two studies con-
ducted in Ghana [27, 28]. For example, most physicians
and midwives at a Kumasi teaching hospital reported
limited knowledge, and had never inserted an IUD [27].
In South Africa, 32 providers at public sector clinics re-
ported a need for further training, and very few spontan-
eously mentioned IUC as a method that they would
recommend [29]. Where specific training has been pro-
vided, however, it appears to have a positive impact on
attitudes. A study of 27 providers from Kenya, who had
been specially trained by the local affiliate of Marie Stopes
International (MSI) in the provision of LARC, docu-
mented positive attitudes towards the LNG-IUD [30].
Providers’ own use of IUC is high in certain settings.
For example, 61% of German obstetrician/gynaecologists
(OB/GYNs) would choose the LNG-IUD for themselves
[31]. LNG-IUD was the most used method among 1001
surveyed OB/GYNs and general practitioners (GPs) from
ten middle-high income countries [32]. An association
was found between the methods providers used and
those they would recommend to clients. However, use of
IUC by professionals may not directly correlate with the
method’s broader popularity. A nationally representative
survey in Spain found that use of IUC among health-
care providers was almost double the rate seen among
the general population [33].
Concerns about side effects
One reason why providers are reluctant to recommend
IUC may be the belief that the method is linked to
serious side effects.
For example, about half of 385 surveyed private sector
providers in Bangladesh were of the opinion that IUDs
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had too many, or too serious, side effects to recommend
[34]. A common concern is the belief in a link between
IUDs and pelvic inflammatory disease (PID), reported in
papers from the US [35–37] and El Salvador [38].
Misconceptions about a link to both PID and to infertil-
ity were prevalent among providers in Pakistan [26]. A
nationally representative survey of 765 French OB/GYNs
and GPs found that a majority believe IUC to be a risk
factor for PID, and also for ectopic pregnancy [39].
Finally, a small South African enquiry noted that two-
thirds of providers thought that the copper-bearing
IUDs represented serious health risks including PID,
ectopic pregnancy, and uterine perforation [29].
Provision to young and nulliparous women
The WHO’s medical eligibility criteria for contraceptive
use recommend copper-bearing IUD and LNG-IUD use
by nulliparous and young women [40]. However, there is
abundant evidence suggesting that providers are particu-
larly reluctant to provide IUC to these groups.
Low willingness to provide IUC to young/nulliparous
women has been documented in several US-based sur-
veys of practitioners [35, 41–45]. For example, according
to a nationally representative survey, only 30% of family
doctors would consider IUC for a teenager and 43% for
a nulliparous patient [41]. The corresponding estimates
among OB/GYNs were 53% and 71%, indicating greater
awareness of eligibility criteria among this specialist
group. Similar differences in awareness between profes-
sional categories were reported in several other US
studies [35, 42–44]. One exception is a survey reporting
that only 30% of physicians and nurses have miscon-
ceptions about the safety of IUC for nulliparous
women [45].
The unwillingness to provide IUC to young/nulliparous
women is not limited to the US. In Nepal, a survey of 345
nurses and midwives established that knowledge of IUC
was uneven with regard to eligibility criteria [46]. A large
majority (83%) of French doctors consider IUC to be con-
traindicated for nulliparous women [39], and Norwegian
GPs rarely counsel young women on the method [47].
Nationally representative surveys of 1444 clinicians
(mostly nurses) showed that in South Africa, 25% would
consider IUDs for adolescents and 33% for nulliparous
women, whereas in Zimbabwe the corresponding esti-
mates were 10% and 12% [48]. Providers in sub-Saharan
African cities may be somewhat less reluctant: about half
of surveyed clinicians working at a teaching hospital in
Ghana would recommend an IUD for a teenager or for a
nulliparous woman [27]. Similarly, among 676 urban
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providers (mostly nurses) in Kenya, between 11% and 20%
restrict IUD access on the grounds of parity or marital sta-
tus, or require prior consent from a third party [49].
A gradient has been observed in the willingness of
practitioners to recommend IUC, increasing by age and
parity. A small study in the US neatly reported that
whereas only 27% of GPs would recommend IUC for a
nulliparous teenager, this figure rose to 50%, 60% and
77% for a nulliparous 21 year-old, a postpartum teen-
ager, and a breastfeeding 21 year old, respectively [50].
In Sweden, willingness to consider IUC as an option
rose linearly with patients’ age [51].
Attempts have been made to explore why providers
are so concerned about providing IUC to these groups.
An online survey of 1862 providers from 15 countries,
mainly OB/GYNs, showed that the main barriers to pro-
viding IUC to nulliparous women were perceived diffi-
culty of insertion, concerns about pain, PID, and
infertility [52]. Almost identical concerns were apparent
in a survey of 1103 contraceptive providers in seven,
mostly European, countries [53]. In addition, one of the
few qualitative studies on this topic showed that a con-
cern about high discontinuation of LARC methods
among young women, as well as about the length of
counselling needed, may act as disincentives among US
professionals [54].
As far as the LNG-IUD is concerned, a multi-country
study in middle and high-income countries showed that
most providers would recommend an LNG-IUD for
limiting, but not for spacing [32]. Similarly, 42% of 2016
German OB/GYNs would never consider an LNG-IUD
for a nulliparous woman [31]. However, there is also evi-
dence that providers may be more willing to provide the
LNG-IUD to nulliparae, compared to the copper-bearing
IUD. Among OB/GYN attendees at an international
conference in Chile, while 80% would not make copper-
bearing IUDs available to nulliparous women, only 10%
would not provide an LNG-IUD [55]. Similarly, a survey
of 701 Australian OB/GYNs revealed that whereas only
39% believed copper-bearing IUDs to be suitable for
nulliparae, this figure rose to 69% for LNG-IUDs [56].
Provision to other categories of women
The literature also shows that some providers are reluc-
tant to provide IUC to other categories of women who
may benefit from the method.
In South Africa and Zimbabwe, for example, 95% of
providers consider IUDs inappropriate for those at risk
of HIV or HIV-positive [48]. Reluctance is also reported
in relation to postpartum provision. US studies indicated
very low awareness of immediate postpartum or post-
abortion insertion of IUC as a sound strategy [42–44],
and only 36% of providers at a teaching hospital in
Ghana said they would recommend immediate postpar-
tum insertion [27].
Finally, a US study showed that the propensity of pro-
viders to recommend IUC was conditioned by the ethni-
city and social status of patients [57]. Health-care
providers were more likely to recommend IUC to black
and Latina women than to white women, although, para-
doxically, among whites they offered it more frequently
to higher status patients.
User/lay perspectives
A total of 43 studies on lay perspectives were identified
(including 9 which also reported on provider perspec-
tives). This literature is dominated by research from the
USA (18 publications), followed by studies from Africa,
Latin America and Asia (14), and from European and
other high-income countries (11).
Low knowledge and misconceptions
The findings of this review suggest that many women
and their partners have low levels of knowledge of IUC
and have unfounded misconceptions about the method.
Several US studies found poor knowledge. Surveys
have found that 55% of young family planning clients
have not heard of the IUD [58], and only 20% of women
attending primary care know that IUC is more effective
than oral contraception [59]. Two papers used survey
data on young men, finding very poor knowledge on
IUC [60, 61]. In one of these, nearly half of participants
believed that IUDs were banned in the US [61].
Qualitative studies in low/middle-income countries
showed a range of concerns about health risks associated
with IUDs, including cancer, ectopic pregnancy, infertility
and harm to the husband during sex [25, 26, 62–65]. Ac-
cording to a large survey of women and men in Pakistan,
the main concern was that IUDs will harm the womb
[66], and two large surveys in Ethiopia ascertained that
one of the main reasons for not using LARC methods was
the fear of infertility [67, 68]. Concerns with fertility im-
pairment were also voiced by the majority of respondents
to a national survey of young women in France [69], and
in a mixed-methods study in the US [70]. A UK survey of
502 young women documented more negative attitudes
towards IUC than towards injectables or implants,
although all three methods invoked concerns about
fertility impairment [71].
While discreetness is considered to be a positive fea-
ture by French users of IUC [72], studies from around
the world report that many other women are concerned
about the fact that the IUD is positioned inside the body.
The authors of a study conducted on the Thai-Burmese
border concluded that this idea fostered imagined and
exaggerated fears [63]. A US-based online survey of
non-IUD users found that the position of the device
Daniele et al. Reproductive Health  (2017) 14:119 Page 5 of 11
worried them [73], a concern also emerging from several
qualitative studies from the US [54, 74–76] and Europe
[77]. A small study of abortion patients in Scotland
found that 24% believed that the device could move
around the body [78].
Concerns about insertion and removal
Findings suggest that some women are concerned about
procedures for insertion and removal of IUC and about
the need for involvement of a health-care provider.
Among 617 postpartum women surveyed in Kenya, the
major reasons for choosing an implant over an LNG-IUD
were less pain, less infringement of modesty, and prefer-
ence for a superficial insertion in the arm [79]. Pain during
insertion is also a concern identified in qualitative and
mixed-methods studies from the US and Europe [54, 70,
71, 74–77]. In Scotland, 34% of abortion patients in a
small survey thought the insertion would be painful [78].
A US-based online survey of non-IUD users found
that the need for provider insertion and removal is itself
considered a disadvantage [73], and two surveys of
abortion-seekers in the US found that self-removal of
IUC would enhance the appeal of the method [80, 81].
In Cambodia, women were concerned that staff would
refuse to remove the device [25].
Benefits and disadvantages of IUC compared to other
methods
Compared to studies seeking the views of the general
population, those focused on women currently using or
interested in using IUC report that the method has sev-
eral perceived advantages and few disadvantages.
Qualitative studies from Cambodia, Pakistan, Nigeria,
Madagascar and the Thailand-Burma border showed
that users appreciated IUDs because of their effective-
ness and long-acting nature [25, 26, 62–65]. These
qualities were among the main positive features men-
tioned by users in six surveys conducted in the US, the
UK, Australia and Pakistan [73, 82–84]. The method’s
forgettability also contributed to satisfaction among
users of IUC in the US and France [72, 85].
In addition, a qualitative study of users and non-users
in seven European countries found that the perceived
advantages of the LNG-IUD include its compatibility
with breastfeeding and a quick return to fertility upon
removal [77]. Rapid return to fertility was also men-
tioned in the study from Nigeria [62], while in Kenya,
postpartum women choosing LNG-IUD over implants
believed that the method had fewer side effects [79]. On
the other hand, respondents from the UK and other
European countries reported the lack of protection
against STIs as a disadvantage of IUC [77, 84].
Finally, affordability was mentioned among the posi-
tive features of IUDs by users in Pakistan [86, 87],
whereas the high cost of the LNG-IUD constituted a
barrier for European women [77].
The effect on menses
The literature suggests that women’s preferences may
vary in relation to the effect of the different types of
IUDs on menses.
One of the most comprehensive US surveys suggests
that women who want to avoid irregular bleeding are
less likely to choose the copper-bearing IUD [82]. Men-
strual irregularity was the main complaint among users
of IUC in a survey in France, though the type of device
was not specified [72], and acted as a disincentive pre-
venting young women in the UK from choosing LARC
methods [71]. A qualitative study found that some US
women choosing an LNG-IUD welcomed the possibility
of amenorrhea, while those choosing a copper-bearing
IUD were motivated by a desire to retain regular menses
[85]. While light, less painful periods are among the
most desirable features of contraceptive methods ac-
cording to Australian women [83], the suppression of
regular menses by the LNG-IUD evokes mixed feelings
among teens and Latina women in the US [54, 88], and
is seen as a disadvantage in Europe [77]. However, a
cohort study of postpartum women in Kenya found
that LNG-IUD users were more likely to find their
bleeding pattern highly acceptable, compared to im-
plant users [89].
The influence of peers and providers
Our findings suggest that peers and providers strongly
influence women’s decision to use IUC.
In the US, a survey of abortion clients showed that
disclosure of personal use of IUC by a provider in-
creased their likelihood of choosing this method [90].
Another US-based survey of women of reproductive age
found that the few women who had been counselled on
IUC and those who had talked to a user of IUC were
more knowledgeable about the method [59].
However, qualitative studies from low-income settings
have shown that while providers are regarded as useful
sources of information, reassurance from friends or rela-
tives who have used IUDs is a crucial factor in attitude
formation [62–64]. In Madagascar, the availability of a
family planning counsellor or friend to accompany the
woman to the clinic for insertion was also important
[64]. US-based qualitative studies show that social net-
works are a valued source of information, though
negative conversations may be more memorable than
positive ones [76, 91].
On the other hand, a survey conducted in five
European countries found that male partners have rela-
tively little influence on choice of IUC, given that about
80% of women do not involve their partners in decisions
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to use female-controlled methods [92]. Finally, a survey
of 261 parents or guardians from the US found that IUC
was the least acceptable method, among seven, for their
teenage daughter [93].
Discussion
This study aimed to summarise recent research findings
on provider and lay perspectives regarding IUC. Results
show that while some health-care providers have up-to-
date knowledge on IUC and most users are satisfied, a
negative reputation of the method persists. Many health-
care providers lack training or regular opportunities for
inserting IUDs and are therefore reluctant to provide
them, and many women have misconceptions or are
concerned about side effects. Most included studies were
conducted in areas where IUD use is moderate or low.
The biases and prejudices that providers and lay people
have against the IUD are remarkably similar across
countries regardless of income level, and contribute to
explaining low uptake. They also shed light on the low
levels of use of IUC compared with implant uptake in
projects that promote both methods equally [94, 95].
Provider-imposed restrictions of access to contracep-
tive methods have been abundantly described in the
contraceptive literature [96]. Barriers described include
marriage or minimum-age restrictions, arbitrary schedules
for return visits, the requirement that women be menstru-
ating, and a variety of process hurdles [97–99]. Some pro-
viders may still adhere to outdated national regulations,
such as system-level restrictions on IUDs and female
sterilisation based on marital status [100].
It is likely that provider reluctance to provide IUC is
due to a combination of outdated knowledge and per-
sonal bias, stemming in part from the fact that IUD in-
sertion is more complex and takes longer than providing
other reversible methods. This may explain providers’
resistance to providing the method to young women,
despite the recent statements by WHO and US profes-
sional organisations on the suitability of IUC for adoles-
cents [40, 101, 102]. It is difficult for new evidence to
change ingrained mentalities, as demonstrated also by
the refusal to provide HIV-positive women with IUDs
[103, 104] and by the persistent obsession with the IUD-
PID link [105]. Until outdated conceptions of eligibility
are dispelled, whole categories of potential users will be
excluded [17].
However, there is probably a large untapped potential
to improve provider attitudes towards IUDs by ensuring
that all professionals involved in family planning re-
ceive regular technical updates and in-service training
[106, 107]. In high-income countries, OB/GYNs are
more likely than general practitioners and nurses to re-
ceive regular updates on contraceptive safety, which
may explain the different levels of knowledge between
these professional categories. The advent of the LNG-
IUD has revived interest in IUC in the USA and Europe,
probably explaining its high uptake among health profes-
sionals themselves and an apparent greater inclination to
provide it. However, the price of LNG-IUD would need
to be reduced for it to become a viable option for low-
income countries [108].
Evidence from sub-Saharan Africa confirms the scar-
city of trained and competent professionals in LARC
method provision, particularly in rural areas [109–111].
It is important that national curricula accommodate suf-
ficient time for practical and theoretical training [112],
and this should be offered to all suitable cadres, including
nurses and midwives [113]. However, the fact that most
initiatives to promote LARC methods have so far been
driven by NGOs rather than national governments has
probably limited progress in this area [24].
All contraceptive methods, including IUC, have advan-
tages and disadvantages. Women reach a rational deci-
sion on contraceptive uptake and method choice largely
based on their perception of potential harm, alongside
other considerations including economic, psychological,
social, familial and personal costs [114, 115].
Among the general population, the existence of un-
founded fears and rumours about modern contracep-
tive methods has been widely reported in the literature
[97, 110, 111, 116]. However, our findings suggest that
misconceptions concerning IUC are largely due to an
inadequate understanding of the mechanism of action,
suggesting that attitudes are likely to be amenable to
improvement through sex education and contraceptive
counselling. Providing accurate information can in-
crease demand for contraception [117], and the uptake
of more effective methods [11]. Regardless of the set-
ting, informing women of the side-effects they might
experience, and especially of the effect on menses, can
increase satisfaction [118], which may, in turn, promote
continuation [20].
However, the formation of attitudes towards contra-
ception and the choice of IUC over other methods are
also influenced by social networks. An analysis of DHS
data from six African countries has shown that the like-
lihood of using contraception is strongly influenced by
how a woman perceives that other female members of
her community will judge her actions [119]. The
provision of accurate information alone may therefore
not be sufficient to improve attitudes, and exposure to
the experiences of other people, even friends of friends,
may be necessary [120]. Media campaigns and targeted
awareness raising in communities may also be useful.
Although our findings show that similar opinions of
IUC are reported by lay people across the world, the
preference for certain methods may also vary by cultural
or geographical context. For example, it has been
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suggested that injectables and implants will be preferred
to IUC where modesty is an important concern, and that
the LNG-IUD would not be popular where amenorrhea
in young women is culturally unacceptable [112]. By
contrast, women in Bangladesh have reported dissatis-
faction with the copper-bearing IUD, because the in-
creased menstrual flow causes disruption to their daily
life [121].
In addition, we found some evidence that concerns
about quality of care and mistrust of facilities may also
limit uptake of IUC. Examples from the literature on low-
and middle-income countries confirm that perceived high
quality of care, and especially trust in health-care pro-
viders, result in higher contraceptive uptake and continu-
ation [122, 123]. In order to attract users, improvements
are therefore required across the various dimensions of
quality of care, from the knowledge and counselling skills
of providers, to the safety and hygienic standards of
facilities [19].
Finally, the review has identified substantial gaps in
the evidence. In low- and middle-income countries, re-
search data on provider and lay perspectives on IUC and
other methods is very patchy. In view of the scale of
investment in family planning in these countries, it is as-
tonishing how little attention has been paid to ascertain-
ing the views of women on specific properties of
contraceptive methods and what considerations are most
important in choosing a method. Similarly, further
studies on provider knowledge, beliefs, attitudes, and
personal use regarding specific methods are justified. For
example, papers from USA and Europe indicate that the
method chosen by providers for their own use influences
their recommendations to women. Yet almost nothing is
known about the contraceptive choices made by many
thousands of family planning staff in Asia, Africa, and
Latin America.
Conclusions
This review systematically explored recently published
literature about provider and lay perspectives on IUC. It
reveals overall low or inaccurate knowledge and miscon-
ceptions about the method as reported by studies from
across the world, but good levels of satisfaction among
users. Given that many people’s negative opinions of
IUDs are based on incorrect information, it seems likely
that concerted efforts to improve awareness and under-
standing of IUC among women and in communities
would boost its popularity. At the same time, increased
training and on-the-job support for providers would in-
crease their willingness to recommend the method, thus
stimulating demand. Further research is needed on pro-
vider and lay perspectives on IUDs and other methods,
especially in low- and middle-income countries.
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